设为首页 加入收藏

TOP

INTEGRILIN(eptifibatide) injection(十六)
2013-10-30 21:38:43 来源: 作者: 【 】 浏览:8800次 评论:0
°–86°F) [see USP Controlled Room Temperature].
Manufactured by: Patheon Italia S.p.A, Ferentino, 03013, Italy
Distributed by: Schering Corporation, a subsidiary of
Whitehouse Station, NJ 08889, USA
U.S. Patent Nos. 5,686,570; 5,747,447; and 5,756,451.
INTEGRILIN is a registered trademark of Millennium Pharmaceuticals, Inc.
Rev 03/2011
31447127T
PRINCIPAL DISPLAY PANEL - 2 mg/mL Carton
NDC 0085-1177-02
200 mg/100 mL vial for
weight-adjusted infusion
(eptifibatide) Injection
INTEGRILIN®
2 mg/mL
SINGLE USE VIAL
FOR INTRAVENOUS
USE ONLY

PRINCIPAL DISPLAY PANEL - 0.75 mg/mL Carton
NDC 0085-1136-01
75 mg/100 mL vial for
weight-adjusted infusion
(eptifibatide) Injection
INTEGRILIN®
0.75 mg/mL
SINGLE USE VIAL
FOR INTRAVENOUS
USE ONLY
Schering®

INTEGRILIN
eptifibatide injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0085-1177
Route of Administration INTRAVENOUS DEA Schedule 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Eptifibatide(Eptifibatide) Eptifibatide 2mg in1mL
Inactive Ingredients
Ingredient Name Strength
Citric Acid Monohydrate 
Sodium Hydroxide 
Product Characteristics
Color  Score 
Shape  Size 
Flavor  Imprint Code 
Contains 
Packaging
# NDC Package Description Multilevel Packaging
1 0085-1177-01 1VIALIn1BOX contains a VIAL
1  10mLIn1VIAL This package is contained within the BOX(0085-1177-01)
2 0085-1177-02 1VIALIn1BOX contains a VIAL
2  100mLIn1VIAL This package is contained within the BOX(0085-1177-02)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020718 03/30/2011 
INTEGRILIN
eptifibatide injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0085-1136
Route of Administration INTRAVENOUS DEA Schedule 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Eptifibatide(Eptifibatide) Eptifibatide 0.75mg in1mL
Inactive Ingredients
Ingredient Name Strength
Citric Acid Monohydrate 
Sodium Hydroxide 
Product Characteristics
Color  Score 
Shape  Size 
Flavor  Imprint Code 
Contains 
Packaging
# NDC Package Description Multilevel Packaging
1 0085-1136-01 1VIALIn1BOX contains a VIAL
1  100mLIn1VIAL This package is contained within the BOX(0085-1136-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020718 03/30/2011 
Labeler -Schering Corporation(001317601)
Establishment
Name Address ID/FEI Operations
Patheon Italia S.p.A.  542639765 MANUFACTURE
Establishment
Name Address ID/FEI Operations
SCHERING CORP  155914674 MANUFACTURE

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 13 14 15 16 下一页 尾页 16/16/16
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Integrilin (Eptifibatide) 下一篇Fusilev

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位